Back to Search
Start Over
Aggressive recurrence of Non-Hodgkin's Lymphoma after successful clearance of hepatitis C virus with direct acting antivirals.
- Source :
-
Annals of hepatology [Ann Hepatol] 2021 Mar-Apr; Vol. 21, pp. 100141. Date of Electronic Publication: 2019 Oct 03. - Publication Year :
- 2021
-
Abstract
- The association of Non-Hodgkin lymphomas and Hepatitis C virus is well documented and antiviral treatments facilitate a virological and hematological response in the majority of HCV related Non-Hodgkin lymphomas. The recent years, direct acting antivirals have made cure possible almost for every HCV patient. Some concerns were raised as regards the frequency and the pattern of recurrence in HCV patients with HCC, treated with these agents. We present a patient with DLBCL, in remission after appropriate treatment, HCV cirrhosis that was cured with the new antivirals and shortly after SVR, he experienced a lethal lymphoma recurrence.<br /> (Copyright © 2019 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.)
- Subjects :
- Biopsy
Humans
Liver virology
Liver Neoplasms diagnosis
Liver Neoplasms virology
Lymphoma, Large B-Cell, Diffuse diagnosis
Lymphoma, Large B-Cell, Diffuse virology
Male
Middle Aged
Positron Emission Tomography Computed Tomography
Sustained Virologic Response
Antiviral Agents therapeutic use
Hepacivirus isolation & purification
Liver diagnostic imaging
Liver Neoplasms drug therapy
Lymphoma, Large B-Cell, Diffuse drug therapy
Lymphoma, Non-Hodgkin drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1665-2681
- Volume :
- 21
- Database :
- MEDLINE
- Journal :
- Annals of hepatology
- Publication Type :
- Academic Journal
- Accession number :
- 31694799
- Full Text :
- https://doi.org/10.1016/j.aohep.2019.08.012